by Qube | Sep 4, 2019 | Uncategorized
Escuela Genetica ATG organises a 1st edition “Monographic course on DNA sequencing: Sanger vs NGS (Next Generation Sequencing)” the 5th and 6th of October. Main goal is to provide with the basic concepts of DNA sequencing by Sanger and NGS methods and...
by Qube | Apr 25, 2019 | Uncategorized
QUBE launches its new web page and corporate identity with the compromise to provide the best services to all companies at the Technology Park.
by Qube | Apr 20, 2019 | Uncategorized
Vivotecnia Research has renovated its instalations at QUBE to extend its offer to preclinical inhalation toxicology by aerosols and smoke. Vivotecnia Research is a contract research laboratory with laboratories and offices at QUBE. Vivotecnia laboratories are...
by Qube | Mar 10, 2019 | Uncategorized
QUBE welcomes VB Devices to the Technology Park. VB devices is a start-up dedicated to the development of two medical devices for use in surgery. Purespume, now in industrialisation phase is a medical device targeted for use by vascular surgeons for the treatment of...
by Qube | Feb 1, 2019 | Uncategorized
Sylentis a company fo the PharmaMar group with offices and laboratories at QUBE announces results of its Phase III Clinical Trial HELIX with tivanisiran (SYL1001) for the treatment of Dry Eye Syndrome. The HELIX trial has demonstrated an improvement (p=0.035) in the...
by Qube | Jan 12, 2019 | Uncategorized
Agrenvec, a company based at QUBE, broadens its portfolio of policlonal antibodies and recombinant proteins expressed in plants. Agreenvec is focused in the expression and purificacion of recombinant proteins in plants. Expresion in plants allows……..
